D.E. Shaw & Co’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-366
| Closed | -$20K | – | 3667 |
|
|
2022
Q3 | $20K | Sell |
366
-2,054
| -85% | -$112K | ﹤0.01% | 3524 |
|
|
2022
Q2 | $144K | Sell |
2,420
-137
| -5% | -$8.15K | ﹤0.01% | 3489 |
|
|
2022
Q1 | $291K | Sell |
2,557
-122
| -5% | -$13.9K | ﹤0.01% | 3457 |
|
|
2021
Q4 | $385K | Sell |
2,679
-489
| -15% | -$70.3K | ﹤0.01% | 3204 |
|
|
2021
Q3 | $694K | Buy |
3,168
+513
| +19% | +$112K | ﹤0.01% | 2681 |
|
|
2021
Q2 | $616K | Sell |
2,655
-2,504
| -49% | -$581K | ﹤0.01% | 2792 |
|
|
2021
Q1 | $1.55M | Sell |
5,159
-617
| -11% | -$186K | ﹤0.01% | 1968 |
|
|
2020
Q4 | $2.17M | Buy |
5,776
+1,719
| +42% | +$646K | ﹤0.01% | 1690 |
|
|
2020
Q3 | $1.25M | Buy |
4,057
+64
| +2% | +$19.7K | ﹤0.01% | 1813 |
|
|
2020
Q2 | $1.5M | Buy |
3,993
+2,060
| +107% | +$775K | ﹤0.01% | 1743 |
|
|
2020
Q1 | $440K | Buy |
1,933
+1,151
| +147% | +$262K | ﹤0.01% | 2198 |
|
|
2019
Q4 | $414K | Buy |
782
+290
| +59% | +$154K | ﹤0.01% | 2257 |
|
|
2019
Q3 | $212K | Buy |
+492
| New | +$212K | ﹤0.01% | 2384 |
|
|
2018
Q2 | – | Sell |
-109
| Closed | -$177K | – | 2620 |
|
|
2018
Q1 | $177K | Sell |
109
-1,416
| -93% | -$2.3M | ﹤0.01% | 2388 |
|
|
2017
Q4 | $2.56M | Buy |
+1,525
| New | +$2.56M | ﹤0.01% | 1395 |
|